TY - JOUR
T1 - Challenges and opportunities for eliminating tuberculosis - Leveraging political momentum of the un high-level meeting on tuberculosis
AU - Sakamoto, Haruka
AU - Lee, Sangnim
AU - Ishizuka, Aya
AU - Hinoshita, Eiji
AU - Hori, Hiroyuki
AU - Ishibashi, Nanao
AU - Komada, Kenichi
AU - Norizuki, Masataro
AU - Katsuma, Yasushi
AU - Akashi, Hidechika
AU - Shibuya, Kenji
N1 - Funding Information:
AMR: Antimicrobial resistance; CSOs: Civil society organizations; GDF: Global Drug Facility; GHIT Fund: Global Health Innovation Technology Fund; GHP: Global Health Policy; iGHP: Institute for Global Health Policy Research; JATA: Japan Anti-Tuberculosis Association; JICA: Japan International Cooperation Agency; MDR-TB: Multi drug resistance – tuberculosis; MSF: Médecins Sans Frontières; NCGM: National Center for Global health and Medicine; NGOs: Non-governmental organizations; R&D: Research and Development; SDGs: Sustainable Development Goals; STBP: Stop-TB partnership; TB: Tuberculosis; UN: United Nation; WHO: World Health Organization
Publisher Copyright:
© 2019 The Author(s).
PY - 2019/1/16
Y1 - 2019/1/16
N2 - Background: As demonstrated by the United Nations High-Level Meeting on tuberculosis (TB) held in September 2018, the political momentum for TB has been increasing. The aim of this study was to analyze the current challenges and opportunities for global TB control and, with specific focus on policies surrounding TB control, to reveal what kinds of efforts are needed to accelerate global TB control. Methods: We organized two expert meetings with the purposes of assessing the current situation and analyzing challenges regarding TB control. By applying Shiffman and Smith's framework which contains four categories; Actor, Ideas, Political context, and Issue characteristics, we analyzed the challenges and opportunities for global TB control based on the findings from the two expert meetings. Results: In the Actor Category, we found that although there has already been active engagement by non-governmental organizations (NGOs), civil society organizations (CSOs) and private sectors, there still remained an area with room for improvement. In particular, the complexities behind varying drug regulatory and procurement systems per country hindered the active participation of the private sector in this area. As for the Ideas category, due to an increasing threat of antimicrobial resistance and growing number of global migrations, TB is now widely recognized as a health security issue rather than a purely health issue. This makes TB an easier target for political attention. As for the Political category, having the UN High-Level Meeting itself is not enough; such meetings must be followed up by actual commitments from heads of states. Lastly the issue characteristic indicates that the amount of funding for R&D for new drugs, vaccines and diagnostics for TB is not at an adequate level, and investment in childhood TB and missing cases are particularly in need. Conclusions: This study provides important insight into the current status of global efforts toward end TB epidemic. The outcomes from the UN high-level meeting on TB need to be closely monitored will be crucial for the progress towards this goal.
AB - Background: As demonstrated by the United Nations High-Level Meeting on tuberculosis (TB) held in September 2018, the political momentum for TB has been increasing. The aim of this study was to analyze the current challenges and opportunities for global TB control and, with specific focus on policies surrounding TB control, to reveal what kinds of efforts are needed to accelerate global TB control. Methods: We organized two expert meetings with the purposes of assessing the current situation and analyzing challenges regarding TB control. By applying Shiffman and Smith's framework which contains four categories; Actor, Ideas, Political context, and Issue characteristics, we analyzed the challenges and opportunities for global TB control based on the findings from the two expert meetings. Results: In the Actor Category, we found that although there has already been active engagement by non-governmental organizations (NGOs), civil society organizations (CSOs) and private sectors, there still remained an area with room for improvement. In particular, the complexities behind varying drug regulatory and procurement systems per country hindered the active participation of the private sector in this area. As for the Ideas category, due to an increasing threat of antimicrobial resistance and growing number of global migrations, TB is now widely recognized as a health security issue rather than a purely health issue. This makes TB an easier target for political attention. As for the Political category, having the UN High-Level Meeting itself is not enough; such meetings must be followed up by actual commitments from heads of states. Lastly the issue characteristic indicates that the amount of funding for R&D for new drugs, vaccines and diagnostics for TB is not at an adequate level, and investment in childhood TB and missing cases are particularly in need. Conclusions: This study provides important insight into the current status of global efforts toward end TB epidemic. The outcomes from the UN high-level meeting on TB need to be closely monitored will be crucial for the progress towards this goal.
KW - Global Fund
KW - Global Health
KW - Health policy
KW - Stop TB partnership
KW - Tuberculosis
KW - United nation high-level meeting
UR - http://www.scopus.com/inward/record.url?scp=85060128900&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060128900&partnerID=8YFLogxK
U2 - 10.1186/s12889-019-6399-8
DO - 10.1186/s12889-019-6399-8
M3 - Article
C2 - 30651096
AN - SCOPUS:85060128900
SN - 1471-2458
VL - 19
JO - BMC Public Health
JF - BMC Public Health
IS - 1
M1 - 76
ER -